(Q80220582)
Statements
Lenalidomide therapy in del(5)(q31)-associated myelofibrosis: cytogenetic and JAK2V617F molecular remissions (English)
Tefferi A
Lasho TL
Mesa RA
Pardanani A
Hanson CA
26 April 2007
1827-1828
scientific article published on 26 April 2007